<DOC>
	<DOCNO>NCT02271217</DOCNO>
	<brief_summary>The objective study determine effect two dose strength dalfampridine-Extended Release ( ER ) tablet , take twice daily 12 week , stable walk deficit subject post-ischemic stroke .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Two Dose Strengths Dalfampridine Extended Release Tablets Treatment Stable Walking Deficits Post-Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>4-Aminopyridine</mesh_term>
	<criteria>Clinical evidence stable walking deficit due ischemic stroke , judge Investigator , base review medical record physical exam . Such deficit present prior stroke attribute primarily condition ( e.g . chronic obstructive pulmonary disease , arthritis ) . Evidence walk deficit objectively support one follow finding clinical examination : 1. obvious slowness movement assign primarily stroke 2. use assistive walking device cane walker 3 . Presence movement pattern deviation stifflegged gait , foot drop , hip hike hip circumduction Modified Rankin Scale score 1 3 , regardless cause ( ) disability Sufficient ambulatory ability independently complete 2MinWT 10MWT ≥ 6 month occurrence recent stroke Woman surgically sterile less 2 year postmenopausal , agree use highly effective birth control method study 3 month last dose investigational product . Woman pregnant , breastfeeding , plan become pregnant History seizure , except simple febrile seizure Moderate severe renal impairment define calculated creatinine clearance ≤ 50 mL/minute use CockcroftGault Equation Suicide attempt within 1 year prior Screening Visit , severe suicidal ideation within 6 month prior Screening Visit , subject significant risk suicidal behavior opinion Investigator Previous use AMPYRA , dalfampridine , fampridine 4aminopyridine ( 4AP ) Initiation serotonin reuptake inhibitor ( SSRI ) within 3 month prior Screening Visit , change dose regimen within 3 month prior Screening Visit Botulinum toxin use within 2 month prior Screening Visit Orthopedic surgical procedure extremity within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Post stroke</keyword>
	<keyword>Ischemic stroke</keyword>
</DOC>